Federal Reserve expected to retain current interest rates in October meeting
In the latest two-day meeting that will conclude on Wednesday, Federal Reserve officials, including Chair Jerome H. Powell, are anticipated to maintain the present
Times Running Out For College As Student Enrollment Dwindles
For many people the cost of getting a degree is the biggest investment they ever make. It’s supposed to be a path to higher
World Bank Says Oil Could Hit $150 But Don’t Hold Your Breath
Global markets were greeted on Tuesday (October 31, 2023) by the news that the World Bank has forecast crude oil prices to rise to
A quarter of student loan borrowers said they’d boycott repayment
As millions of student loan borrowers prepare to get their first student loan bills in more than three years, some said they would refuse
28-year-old makes over $210,000 a year working in a hospital—without going to med school
This story is part of CNBC Make It’s Millennial Money series, which details how people around the world earn, spend and save their money. If you
Microsoft releases big Windows 11 update with Copilot AI assistant included
Microsoft on Tuesday said it started rolling out the next major update to its Windows 11 PC operating system. The new version contains a
Steve Ballmer, who started as Bill Gates’ assistant, is the 5th-richest person in the world
Bill Gates’ former assistant at Microsoft is now the fifth-richest person in the world, per Bloomberg’s tally, and only one spot behind Gates on
Allied Properties: 9.3% Implied Cap Rate Improves Odds Of Bulls Winning (TSX:AP.UN:CA)
All values are in CAD unless noted otherwise. Allied Properties Real Estate Investment Trust (OTC:APYRF)(TSX:AP.UN:CA) holds a portfolio of 200 income earning properties, spanning
Blinken and Austin make the case that separating Israel and Ukraine funding would embolden America’s enemies
US Secretary of State Antony Blinken and Defense Secretary Lloyd Austin on Tuesday pressed lawmakers to urgently pass the Biden administration’s $105 billion national
Sarepta Stock Sinks 43% on Uncertain Future for Its Gene Therapy
Shares of Sarepta Therapeutics dropped by nearly half on Tuesday amid uncertainty about the future of the company’s $3.2 million gene therapy for Duchenne
Most Read
